Standpoint Research Downgrades Walgreens (WAG)

Standpoint Research has downgraded shares of Walgreen Company WAG from Buy to Hold today. The stock has gained 30% in the last 90 days compared to a 15% gain for CVS Caremark CVS and 13% for the S&P 500. Standpoint analyst Ronnie Moas wrote, "the shares are now fairly valued at 17X peak earnings from 2007-2008, 14.6X 2011 estimates and 12.8X estimates for 2012." During Monday's trading session, WAG shares have fallen 1.68% to $36.24. The stock was also downgraded at Citigroup today.